THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
Objective. To evaluated effect of adalimumab treatment on activity of arthritis, enthesitis, psoriasis and functional status in PsA patients (pts). Subjects and methods. 18 pts with active PsA (12 female, 6 male), median age 43,1±10,2 years (yrs) (range 24-56), median duration of psoriasis 16,7±9,6...
Main Authors: | Elena Yurievna Loginova, T V Korotaeva, N V Klimova, E N Aleksandrova, L N Denisov, Sh F Erdes |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2010-06-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/586 |
Similar Items
-
ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
by: Tatyana G. Sidorcika, et al.
Published: (2018-04-01) -
A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week)
by: Yuki Nanke, et al.
Published: (2019-04-01) -
Ultrasound Enthesitis in Psoriasis Patients with or without Psoriatic Arthritis, a Cross-Sectional Analysis
by: Mihaela Agache, et al.
Published: (2022-10-01) -
Nail Ultrasound in Psoriasis and Psoriatic Arthritis—A Narrative Review
by: Mihaela Agache, et al.
Published: (2023-06-01) -
SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01)